Versions of CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E - Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses on LawServer 2024 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses 2023 CFR > Title 21 > CHAPTER I > SUBCHAPTER D > PART 312 > Subpart E – Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses 2022 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses 2021 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses 2020 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses 2019 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses 2016 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses 2015 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses 2014 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart E – Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses
